Statistics for Neoadjuvant chemotherapy and pathologic complete response in HR+/HER2-Breast Cancer: impact of Tumor Ki67 and ER status
Total visits
| views | |
|---|---|
| Neoadjuvant chemotherapy and pathologic complete response in HR+/HER2-Breast Cancer: impact of Tumor Ki67 and ER status | 0 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |